Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
IndustryARC
www.industryarc.com/
Venkat Reddy
venkat@industryarc.com
(+1) 970-236-3677

Bookmark and Share
Spine Biologics Market - Forecast 2021 - 2026
Rising advancement in spine biologics procedure increases the treatment of spine disorder in a safe and effective way which is the major factor driving the growth of Spine Biologics Market


Spine Biologics Market
BriefingWire.com, 12/02/2021 - Spine Biologics Market Spine Biologics Market size is projected to reach $2,700 million by 2026, growing at a CAGR of 5.9% over 2021-2026. Spinal biologics is a kind of biological material that is used for healing the condition in the spinal. The use of spine biologics becomes an important component in any spinal fusion surgery. Spine biologics helps to provide a mechanism for the growth of bone. The biologics are commonly known as bone graft substitute that helps to improve the growth of new bone. Spine biologics provides a great option for the treatment of degenerative disc disease by reducing chronic back pain.

Key Takeaways

In 2020, North America dominated the Spine Biologics Market owing to growing advancement in the healthcare sector and rising adoption of a variety of advanced technologies for treating spinal injuries. Moreover, the rising number of people suffering from spinal disorders increases the adoption of spine biologics procedures which in turn enhancing the market growth.

Growing issue in spine among population rising the adoption of spine biologics that helps to reduce various diseases such as degenerative disc diseases, spinal cord injuries, etc. and rising advancement in spine biologics procedure increases the treatment of spine disorder in a safe and effective way are improving the growth of the Spine Biologics Market.

The prominent manufacturers operating in the market will be provided a detailed analysis of Strengths, Weaknesses, and Opportunities in the Spine Biologics Market report.

Download Sample Report @ www.industryarc.com/pdfdownload.php?id=16837

Spine Biologics Segment Analysis – By Geography

North America dominated the Spine Biologics Market with a major share of 40% in 2020. This is owing to growing advancement in the healthcare sector and the rising adoption of a variety of advanced technologies for treating spinal injuries. Moreover, the rising number of people suffering from spinal disorders increases the adoption of spine biologics procedures which in turn enhancing the market growth. In the U.S., more than 1 million people are suffering from spinal cord injury according to the National Spinal Cord Injury Statistical Center in 2019 that furthers rising the adoption of spine biologics.

Spine Biologics Market Drivers

Growing issue in spine among population rising the adoption of spine biologics that helps to reduce various diseases such as degenerative disc diseases, spinal cord injuries and many more

Rising advancement in spine biologics procedure increases the treatment of spine disorder in a safe and effective way

Spine Biologics Landscape

Spine Biologics top 10 companies are Zimmer Biomet Holdings inc, Nuvasive Inc, Depuy Synthes, Orthofix International N.V, K2M, Inc, Exactech, Inc, Biogennix, Arthrex, Inc., Wright Medical Technology, Aziyo Biologics.

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2022 Proserve Technology, Inc.